A composite, off-the-shelf osteoinductive material for large, vascularized bone flap prefabrication

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Current bone repair strategies often rely on osteoconductive materials or isolated growth factors.
• Engineered human Mesenchymal stromal cell-derived Chondrogenic Matrices (MB-CM) show osteoinductive potential for bone tissue engineering.
• Scaling up MB-CM for large bone defects requires optimizing its utilization and efficiency.

Purpose of the Study:

• To investigate if combining MB-CM with an osteoconductive material enhances bone formation efficiency.
• To determine the optimal ratio of MB-CM to SmartBone® for inducing bone regeneration.
• To evaluate the efficacy of the composite material in a scaled-up, vascularized bone defect model.

Main Methods:

• Testing various volumetric ratios of MB-CM and SmartBone® composites.
• Ectopic implantation of composites in mice to assess bone formation capacity.
• Evaluation of the most effective composite in a rat prefabricated bone-flap model (0.8 cm³).

Main Results:

• A composite with as little as 25% MB-CM induced significant bone formation and fusion across SmartBone® granules in mice.
• In the rat flap model, the composite generated new bone (31% cross-sectional area), including marrow and vascular elements.
• The composite demonstrated efficient bone induction throughout the flap volume.

Conclusions:

• Combining MB-CM with osteoconductive SmartBone® is an effective strategy for bone tissue engineering.
• This approach reduces the required amount of MB-CM, enabling its use in larger bone grafts.
• The findings support the clinical application of this composite for challenging bone reconstruction scenarios.